AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Linda Loyd
Sep. 28--Sanofi-Aventis, the world's third-largest pharmaceutical company, will keep its U.S. research and drug development headquarters in Malvern, a company official said yesterday.
The 750 scientists and researchers at the Great Valley Corporate Center in Malvern were part of Sanofi-Synthelabo SA, the French drug maker which in August bought larger rival Aventis SA for $61.9 billion.
Sanofi and Aventis agreed in April to combine after Sanofi raised its takeover offer.
"Great Valley is going to stay where it is" as a U.S. research and drug development center, said company spokesman Marc Greene, who said details on ...
Source: HighBeam Research, Sanofi-Aventis to keep U.S. research headquarters in Malvern, Pa.